Author: Tayaza Fadason; Sreemol Gokuladhas; Evgeniia Golovina; Daniel Ho; Sophie Farrow; Denis Nyaga; Hong Pan; Neerja Karnani; Conroy Wong; Antony Cooper; William Schierding; Justin M. O’Sullivan
Title: A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors Document date: 2020_4_15
ID: 5r0u2mmo_29
Snippet: Interleukin expression is responsible for irreversible, pathological changes associated with 216 SARS-CoV infection in the lung (e. g. [44] ). Human coronavirus has been shown to fine-tune 217 NF-κB signaling [45] . PIR encodes a non-heme iron binding protein that is a redox switch that 218 modulates the binding of p65 (RelA) to NF-κB responsive promoters [46] . NF-κB regulates 219 multiple immune function aspects, including the production of .....
Document: Interleukin expression is responsible for irreversible, pathological changes associated with 216 SARS-CoV infection in the lung (e. g. [44] ). Human coronavirus has been shown to fine-tune 217 NF-κB signaling [45] . PIR encodes a non-heme iron binding protein that is a redox switch that 218 modulates the binding of p65 (RelA) to NF-κB responsive promoters [46] . NF-κB regulates 219 multiple immune function aspects, including the production of pro-inflammatory 220 cytokines [47] . Therefore, it is notable that repressor regulatory sequences for PIR sit within 221 the ACE2 gene (Fig 2A) . We postulate that the chromatin modifications that silence ACE2 222 expression upon early stage infection activate the PIR repressor ( Fig 2B) . This reduces 223 responsiveness of NF-κB, and thereby delays the expected and needed anti-viral response. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.14.042002 doi: bioRxiv preprint
Search related documents:
Co phrase search for related documents- anti viral response and human coronavirus: 1
- anti viral response and Interleukin expression: 1
- anti viral response and lung SARS cov infection: 1, 2, 3
- anti viral response and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- anti viral response and SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
- anti viral response and stage infection: 1, 2, 3, 4
- bind protein and early stage infection: 1
- bind protein and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- bind protein and immune function: 1, 2
- bind protein and lung SARS cov infection: 1, 2, 3
- bind protein and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- bind protein and SARS cov infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68
- bind protein and stage infection: 1, 2
- chromatin modification and fine tune: 1
- chromatin modification and immune function: 1
- chromatin modification and SARS cov: 1, 2
- chromatin modification and SARS cov infection: 1
- early stage infection and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
- early stage infection and immune function: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date